| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44012633 | HTLV-1 | ENSG00000106804.10 | protein_coding | C5 | No | No | 727 | P01031 |
| TVIS44006470 | HTLV-1 | ENSG00000106804.10 | protein_coding | C5 | No | No | 727 | P01031 |
| TVIS44026187 | HTLV-1 | ENSG00000106804.10 | protein_coding | C5 | No | No | 727 | P01031 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | C5 |
|---|---|
| DrugBank ID | DB00028 |
| Drug Name | Human immunoglobulin G |
| Target ID | BE0000855 |
| UniProt ID | P01031 |
| Regulation Type | binder |
| PubMed IDs | 20441428; 17351760; 17911465 |
| Citations | Baerenwaldt A, Biburger M, Nimmerjahn F: Mechanisms of action of intravenous immunoglobulins. Expert Rev Clin Immunol. 2010 May;6(3):425-34. doi: 10.1586/eci.10.9.@@Negi VS, Elluru S, Siberil S, Graff-Dubois S, Mouthon L, Kazatchkine MD, Lacroix-Desmazes S, Bayry J, Kaveri SV: Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol. 2007 May;27(3):233-45. Epub 2007 Mar 11.@@Siberil S, Elluru S, Graff-Dubois S, Negi VS, Delignat S, Mouthon L, Lacroix-Desmazes S, Kazatchkine MD, Bayry J, Kaveri SV: Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective. Ann N Y Acad Sci. 2007 Sep;1110:497-506. |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | PA164754884 |
| ChEMBL |
